Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03799380 · ClinicalTrials.gov registry record · NA
DRIHNC - Dehydration Reduction in Head & Neck Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT03799380 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 41 participants.
The verdict
NCT03799380, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to decrease the rate of visits to the Emergency Department (ED) and Acute Care Clinics (ACC) for dehydration for head \& neck (H\&N) and esophageal cancer patients that are given Gatorade while receiving radiation therapy with or without chemotherapy.
Interventions
- DIETARY_SUPPLEMENT Gatorade G2
- DIETARY_SUPPLEMENT Standard of care nutritional support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-11-05 |
| Est. Completion | 2021-05-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03799380
The ClinicalTrials.gov registry entry for NCT03799380 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gatorade G2 is the first listed.
NCT03799380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03799380 about?
NCT03799380 is a clinical study titled "DRIHNC - Dehydration Reduction in Head & Neck Cancer". The purpose of this study is to decrease the rate of visits to the Emergency Department (ED) and Acute Care Clinics (ACC) for dehydration for head \& neck (H\&N) and esophageal cancer patients that are given Gatorade while receiving radiation therapy with or without chemotherapy.
What is the current status of trial NCT03799380?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2019-11-05. Estimated completion is 2021-05-05.
What interventions are being tested in trial NCT03799380?
The interventions under investigation include: Gatorade G2 (DIETARY_SUPPLEMENT), Standard of care nutritional support (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03799380?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.